Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSMOS: Rosuvastatin IVUS Study in Japanese CHD Patients
NCT00329160Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2005
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin in hypercholesterolemia and coronary heart disease (CHD), sponsored by AstraZeneca. Primary endpoint: Percent Change From Baseline to Week 76 in the Plaque Volume (PV). Started Oct 2005; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacoronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00329160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329160.